Skip to main content

Elmind Capital, LP

SEC CIK
0002052213
Latest filing
Aug 14, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
460,000
Value
$11.2M
% of portfolio
2.8%
Quarters held
3
Since Q4 2025
Holdings of NRIX by Elmind Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026460,000$11.2M2.8%00.0%UnchangedHolders
Q1 2026460,000$7.13M2.0%00.0%UnchangedHolders
Q4 2025460,000$8.73M2.6%–No prior filingHolders